Back to 
RTW Investments, LP
RTW Investments, LP
DSGN
Showing 0 of 3 quarters
Position history for RTW Investments, LP's holdings in Design Therapeutics, Inc.
No. RTW Investments exited its DSGN (Design Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 2,512,986 shares worth $5.9M. RTW Investments first reported DSGN in Q2 2023 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DSGN: Citadel Advisors LLC, RA Capital Management, L.P., Point72 Asset Management, L.P.